Dropwise additive manufacturing of pharmaceutical products for melt-based dosage forms

Journal of Pharmaceutical Sciences

Volumn 104, Issue 5, 2015, Pages 1641-1649

  Içten, Elçin ^a   Giridhar, Arun ^a   Taylor, Lynne S ^b   Nagy, Zoltan K ^a   Reklaitis, Gintaras V ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Dissolution; Drug delivery systems; Oral drug delivery; Polymers; Process analytical technology; Processing; Quality by design; Solid dispersion; Solid dosage form; Surfactants

Indexed keywords

MACROGOL; MACROGOL 3350; NAPROXEN; POLYMER; DRUG; DRUG DOSAGE FORM;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DROPWISE ADDITIVE MANUFACTURING OF PHARMACEUTICAL PRODUCT; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MELT BASED DOSAGE FORM; MELTING POINT; MOLECULAR WEIGHT; SOLID STATE; SURFACE PROPERTY; VISCOSITY; X RAY DIFFRACTION; MEDICINAL CHEMISTRY; PROCEDURES; SOLUBILITY; SYNTHESIS;

CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; X-RAY DIFFRACTION;

EID: 84926460129     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24367     Document Type: Article

References (34)

1. Laínez JM, Schaefer E, Reklaitis GV. 2012. Challenges and opportunities in enterprise-wide optimization in the pharmaceutical industry. Comput Chem Eng 47(FOCAPO 2012):19-28.
2. Gernaey KV, Cervera-Padrell AE, Woodley JM. 2012. A perspective on PSE in pharmaceutical process development and innovation. Comput Chem Eng 42:15-29.
3. US Food and Drug Administration. 2004. Guidance for industry guidance for industry PAT - A framework for innovative pharmaceutical development, manufacturing and quality assurance.
4. Stephanopoulos G, Reklaitis GV. 2011. Process systems engineering: From Solvay to modern bio- and nanotechnology. Chem Eng Sci 66(19):4272-4306.
5. Hirshfield L, Giridhar A, Taylor LS, Harris MT, Reklaitis GV. 2014. Dropwise additive manufacturing of pharmaceutical products for solvent-based dosage forms. J Pharm Sci 103(2):496-506.
6. de Gans B-J, Duineveld PC, Schubert US. 2004. Inkjet printing of polymers: State of the art and future developments. Adv Mater 16(3):203-213.
7. Laínez JM, Orcun S, Pekny JF, Reklaitis GV, Suvannasankha A, Fausel C, Anaissie EJ, Blau GE. 2014. Comparison of an assumption-free Bayesian approach with optimal sampling schedule to a maximum a posteriori approach for personalizing cyclophosphamide dosing. Pharmacotherapy 34(4):330-335.
8. Laínez JM, Blau G, Mockus L, Orcun S, Reklaitis GV. 2011. Pharmacokinetic based design of individualized dosage regimens using a Bayesian approach. Ind Eng Chem Res 50:5114-5130.
9. Blau GE, Orcun S, Laínez JM, Reklaitis GV, Suvannasankha A, Fausel C, Anaissie EJ. 2013. Validation of a novel approach for dose individualization in pharmacotherapy using gabapentin in a proof of principles study. Pharmacotherapy 33(7):727-735.
10. Clarke AJ, Doughty DG, Fiesser FH, Wagner DS. 2012. Patent US 8252234.
11. Derby B. 2012. Inkjet printing of functional and structural materials: Fluid property requirements, feature stability, and resolution. Annu Rev Mater Res 40(1):395-414.
12. Nagy ZK, Braatz RD. 2012. Advances and new directions in crystallization control. Annu Rev Chem Biomol Eng 3:55-75.
13. Icten E, Nagy ZK, Reklaitis GV. 2014. Supervisory control of a drop on demand mini-manufacturing system for pharmaceuticals. Proc 24th Eur Symp Comput Aided Process Eng, Comp Aided Chem Eng 33:535-540.
14. Joglekar GS, Giridhar A, Reklaitis GV. 2014. A workflow modeling system for capturing data provenance. Comput Chem Eng 67:148-158.
15. Baird JA, Van Eerdenbrugh B, Taylor LS. 2010. A classification system to assess the crystallization tendency of organic molecules from undercooled melts. J Pharm Sci 99(9):3787-3806.
16. Trasi NS, Taylor LS. 2012. Effect of polymers on nucleation and crystal growth of amorphous acetaminophen. Cryst Eng Comm 14(16):5188.
17. Mosquera-Giraldo LI, Trasi NS, Taylor LS. 2014. Impact of surfactants on the crystal growth of amorphous celecoxib. Int J Pharm 461(1-2):251-257.
18. Leuner C. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50(1):47-60.
19. Yang M, Wang P, Huang C-Y, Ku MS, Liu H, Gogos C. 2012. Solid dispersion of acetaminophen and poly(ethylene oxide) prepared by hot-melt mixing. Int J Pharm 395(1-2):53-61.
20. Shah S, Maddineni S, Lu J, Repka MA. 2013. Melt extrusion with poorly soluble drugs. Int J Pharm 453(1):233-252.
21. Reis N, Derby B. 2000. Ink jet deposition of ceramic suspensions: Modeling and experiments of droplet formation. Mat Res Soc Symp Proc 624:117-122.
22. Dong HM, Carr WW, Morris JF. 2006. An experimental study of drop-on-demand drop formation. Phys Fluids, 18(7):16.
23. Hugli H, Gonzalez J. 2000. Drop volume measurements by vision. Imaging 2000, SPIE Electron Imaging Conf 3966(11):60-66.
24. Yarin AL. 2006. Drop impact dynamics: Splashing, spreading, receding, bouncing. Annu Rev Fluid Mech 38(1):159-192.
25. Hsu H, Toth SJ, Simpson GJ, Taylor LS, Harris MT. 2013. Effect of substrates on naproxen-polyvinylpyrrolidone solid dispersions formed via the drop printing technique. J Pharm Sci 102(2):638-648.
26. Fujiwara M, Nagy ZK, Chew JW, Braatz RD. 2004. First-principles and direct design approaches for the control of pharmaceutical crystallization. J Process Control 15(5):493-504.
27. De Beer T, Burggraeve A, Fonteyne M, Saerens L, Remon JP, Vervaet C. 2011. Near infrared and Raman spectroscopy for the in-process monitoring of pharmaceutical production processes. Int J Pharm 417(1-2):32-47.
28. Yu LX, Lionberger RA, Raw AS, D'Costa R, Wu H, Hussain AS. 2004. Applications of process analytical technology to crystallization processes. Adv Drug Deliv Rev 56(3):349-369.
29. Zhu Q, Toth SJ, Simpson GJ, Hsu H-Y, Taylor LS, Harris MT. 2013. Crystallization and dissolution behavior of naproxen/polyethylene glycol solid dispersions. J Phys Chem B 117(5):1494-1500.
30. Kabanov AV, Batrakova EV, Alakhov VY. 2002. Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 82(2-3):189-212.
31. Patel K, Bahadur P, Guo C, Ma JH, Liu HZ, Yamashita Y, Khanal A, Nakashima K. 2007. Salt induced micellization of very hydrophilic PEO-PPO-PEO block copolymers in aqueous solutions. Eur Polym J 43(5):1699-1708.
32. Kwon SH, Kim SY, Ha KW, Kang MJ, Huh JS, ImTJ, Kim YM, Park YM, Kang KH, Lee S, Chang JY, Lee J, Choi YW. 2007. Pharmaceutical evaluation of genistein-loaded pluronic micelles for oral delivery. Arch Pharm Res 30(9):1138-1143.
33. Batrakova EV, Han HY, Miller DW, Kabanov AV. 1998. Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm Res 15(10):1525-1532.
34. Batrakova EV, Kabanov AV. 2008. Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 130(2):98-106.